Susquehanna Cuts Stem (NYSE:STEM) Price Target to $10.00

Stem (NYSE:STEM) had its price target cut by Susquehanna from $21.00 to $10.00 in a research note published on Thursday morning, MarketBeat Ratings reports. They currently have a neutral rating on the stock.

STEM has been the topic of several other research reports. UBS Group reaffirmed a “neutral” rating and set a $12.00 price target (down from $18.00) on shares of Stem in a research note on Tuesday, March 10th. Weiss Ratings raised Stem from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, March 10th. Finally, Wall Street Zen lowered Stem from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. Four investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus target price of $15.75.

Stem Stock Performance

Stem stock opened at $9.54 on Thursday. The firm has a market cap of $81.27 million, a P/E ratio of -1.01 and a beta of 1.40. The business’s fifty day moving average is $10.79 and its two-hundred day moving average is $16.03. Stem has a 52 week low of $5.81 and a 52 week high of $32.23.

Stem (NYSE:STEM) last posted its quarterly earnings data on Wednesday, March 4th. The company reported ($1.85) EPS for the quarter, topping analysts’ consensus estimates of ($1.96) by $0.11. The business had revenue of $47.14 million during the quarter, compared to analyst estimates of $39.05 million. On average, equities research analysts predict that Stem will post -0.52 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Arun Narayanan sold 5,145 shares of the company’s stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $11.12, for a total value of $57,212.40. Following the completion of the sale, the chief executive officer owned 12,980 shares in the company, valued at approximately $144,337.60. This represents a 28.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders sold a total of 10,366 shares of company stock valued at $114,190 in the last ninety days. Corporate insiders own 5.10% of the company’s stock.

Institutional Investors Weigh In On Stem

A number of institutional investors and hedge funds have recently added to or reduced their stakes in STEM. IFP Advisors Inc increased its holdings in Stem by 258.1% in the third quarter. IFP Advisors Inc now owns 1,479 shares of the company’s stock valued at $26,000 after purchasing an additional 1,066 shares during the last quarter. International Assets Investment Management LLC bought a new stake in shares of Stem in the fourth quarter worth about $29,000. Skandinaviska Enskilda Banken AB publ bought a new stake in shares of Stem in the third quarter worth about $55,000. Bridgeway Capital Management LLC bought a new stake in shares of Stem in the second quarter worth about $97,000. Finally, Zweig DiMenna Associates LLC bought a new stake in shares of Stem in the fourth quarter worth about $125,000. Institutional investors own 61.63% of the company’s stock.

Stem News Roundup

Here are the key news stories impacting Stem this week:

• Positive Sentiment: March quarter reported better-than-expected results: STEM posted (‑$1.85) EPS versus consensus (‑$1.96) and revenue of $47.14M vs. estimates of ~$39.05M — a near-term fundamental positive that supports valuation while the company works toward profitability.
• Neutral Sentiment: Local and educational STEM initiatives (Ivy Tech free summer workshops) and youth programs are being widely covered, but these community/education stories are unrelated to Stem, Inc.’s business and are unlikely to move the stock materially. Ivy Tech offering free STEM summer workshops
• Neutral Sentiment: Coverage on stem-cell research and therapies (e.g., Parkinson’s stem-cell work at University of Miami and other scientific stories) uses the word “stem” but does not pertain to Stem, Inc.’s energy-storage business and therefore has limited relevance to the stock. Parkinson’s stem-cell therapy article
• Negative Sentiment: Susquehanna cut its price target on STEM from $21.00 to $10.00 and moved to a “neutral” rating — a downgrade that directly pressures sentiment and likely explains today’s selloff; the new $10 PT implies only modest upside from current levels. Susquehanna price-target cut

About Stem

Stem, Inc is a technology company specializing in AI-driven energy storage and optimization solutions for commercial, industrial and utility customers. The company delivers integrated hardware and software systems that enable clients to manage energy consumption, reduce peak demand charges and provide ancillary services to the power grid. By combining battery storage hardware with advanced machine-learning algorithms, Stem helps organizations align energy usage with cost-saving opportunities while supporting grid reliability and renewable integration.

At the core of Stem’s offering is its Athena software platform, which uses real-time data and predictive analytics to forecast energy needs and automatically dispatch stored energy when it is most valuable.